Does NIVOLUMAB Cause Hyperpyrexia? 24 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 24 reports of Hyperpyrexia have been filed in association with NIVOLUMAB (OPDIVO). This represents 0.0% of all adverse event reports for NIVOLUMAB.
24
Reports of Hyperpyrexia with NIVOLUMAB
0.0%
of all NIVOLUMAB reports
2
Deaths
16
Hospitalizations
How Dangerous Is Hyperpyrexia From NIVOLUMAB?
Of the 24 reports, 2 (8.3%) resulted in death, 16 (66.7%) required hospitalization, and 1 (4.2%) were considered life-threatening.
Is Hyperpyrexia Listed in the Official Label?
Yes, Hyperpyrexia is listed as a known adverse reaction in the official FDA drug label for NIVOLUMAB.
What Other Side Effects Does NIVOLUMAB Cause?
Death (11,216)
Malignant neoplasm progression (9,363)
Off label use (5,208)
Diarrhoea (4,692)
Fatigue (3,709)
Pyrexia (3,454)
Intentional product use issue (3,297)
Rash (2,816)
Nausea (2,805)
Decreased appetite (2,619)
What Other Drugs Cause Hyperpyrexia?
TRASTUZUMAB (146)
RITUXIMAB (139)
CYCLOPHOSPHAMIDE (133)
PACLITAXEL (100)
ZOLEDRONIC ACID (96)
OXALIPLATIN (94)
CARBOPLATIN (73)
GEMCITABINE (72)
VINCRISTINE (69)
DABRAFENIB (68)
Which NIVOLUMAB Alternatives Have Lower Hyperpyrexia Risk?
NIVOLUMAB vs NIVOLUMAB\RELATLIMAB-RMBW
NIVOLUMAB vs NIZATIDINE
NIVOLUMAB vs NOMEGESTROL
NIVOLUMAB vs NORDAZEPAM
NIVOLUMAB vs NOREPINEPHRINE